D Perrault

865 total citations
16 papers, 610 citations indexed

About

D Perrault is a scholar working on Oncology, Cancer Research and Dermatology. According to data from OpenAlex, D Perrault has authored 16 papers receiving a total of 610 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Oncology, 5 papers in Cancer Research and 4 papers in Dermatology. Recurrent topics in D Perrault's work include Cancer Treatment and Pharmacology (12 papers), Breast Cancer Treatment Studies (4 papers) and Chemotherapy-induced cardiotoxicity and mitigation (4 papers). D Perrault is often cited by papers focused on Cancer Treatment and Pharmacology (12 papers), Breast Cancer Treatment Studies (4 papers) and Chemotherapy-induced cardiotoxicity and mitigation (4 papers). D Perrault collaborates with scholars based in Canada, United States and India. D Perrault's co-authors include George Deboer, Ian F. Tannock, Charles Erlichman, Shai Fine, N F Boyd, Heather Sutherland, Gail Larocque, Beth Fisher, B. Norris and K. I. Pritchard and has published in prestigious journals such as Journal of Clinical Oncology, Annals of Oncology and European Journal of Cancer.

In The Last Decade

D Perrault

16 papers receiving 580 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
D Perrault Canada	11	382	162	120	109	107	16	610
H. B. Muss United States	13	380 1.0×	200 1.2×	99 0.8×	193 1.8×	35 0.3×	28	636
H.T. Mouridsen Denmark	12	566 1.5×	273 1.7×	310 2.6×	150 1.4×	119 1.1×	33	787
G Martz Switzerland	14	336 0.9×	134 0.8×	122 1.0×	122 1.1×	48 0.4×	36	535
William Hyman United States	11	766 2.0×	483 3.0×	179 1.5×	83 0.8×	155 1.4×	21	1.0k
Robert W. Frelick United States	10	500 1.3×	418 2.6×	159 1.3×	98 0.9×	158 1.5×	20	836
D F Hayes United States	8	464 1.2×	329 2.0×	152 1.3×	234 2.1×	100 0.9×	12	765
Philip Iau Singapore	16	352 0.9×	220 1.4×	69 0.6×	122 1.1×	89 0.8×	28	728
C.G. Alexopoulos Greece	15	421 1.1×	131 0.8×	219 1.8×	40 0.4×	106 1.0×	34	789
Frank Peters Netherlands	13	425 1.1×	236 1.5×	323 2.7×	60 0.6×	81 0.8×	32	754
Rémy Largillier France	12	478 1.3×	314 1.9×	144 1.2×	71 0.7×	115 1.1×	32	728

Countries citing papers authored by D Perrault

Since Specialization

Citations

This map shows the geographic impact of D Perrault's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by D Perrault with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites D Perrault more than expected).

Fields of papers citing papers by D Perrault

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by D Perrault. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by D Perrault. The network helps show where D Perrault may publish in the future.

Co-authorship network of co-authors of D Perrault

This figure shows the co-authorship network connecting the top 25 collaborators of D Perrault. A scholar is included among the top collaborators of D Perrault based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with D Perrault. D Perrault is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

16 of 16 papers shown

Perrault, D, et al.. (1997). Changes in women's breast cancer screening practices, knowledge, and attitudes in Ottawa-Carleton since 1991.. PubMed. 87(5). 333–8. 14 indexed citations

Perrault, D, et al.. (1996). Phase II study of the progesterone antagonist mifepristone in patients with untreated metastatic breast carcinoma: a National Cancer Institute of Canada Clinical Trials Group study.. Journal of Clinical Oncology. 14(10). 2709–2712. 81 indexed citations

Tomiak, Anna, Jonathan C. Yau, S. Huan, et al.. (1994). Duration of intravenous antibiotics for patients with neutropenic fever. Annals of Oncology. 5(5). 441–445. 18 indexed citations

Levine, Mark N., V. Bramwell, Kathleen I. Pritchard, et al.. (1993). The Canadian Experience with Intensive Fluorouracil, Epirubicin and Cyclophosphamide in Patients with Early Stage Breast Cancer. Drugs. 45(Supplement 2). 51–59. 5 indexed citations

Piccart, Martine, Joseph Kerger, Eva Tomiak, & D Perrault. (1992). Systemic treatment for locally advanced breast cancer: What we still need to learn after a decade of multimodality clinical trials. European Journal of Cancer. 28(2-3). 667–672. 13 indexed citations

Eisenhauer, Elizabeth A., Kathleen I. Pritchard, D Perrault, Shailendra Verma, & Joseph L. Pater. (1990). Activity of intravenous menogaril in patients with previously untreated metastatic breast cancer. Investigational New Drugs. 8(3). 283–287. 6 indexed citations

Stewart, David J., et al.. (1990). Phase I study of idarubicin administered orally on a daily × 3 schedule. Investigational New Drugs. 8(3). 275–281. 2 indexed citations

Stewart, David J., Jean A. Maroun, Shailendra Verma, D Perrault, & Robert H. Earhart. (1989). Phase I Study of Weekly Intravenous Administration of Menogaril to Adults with Solid Tumors. American Journal of Clinical Oncology. 12(6). 511–518. 8 indexed citations

Ginsburg, A D, et al.. (1989). Systemic adjuvant therapy for node-negative breast cancer.. PubMed. 141(5). 381–7. 3 indexed citations

10.

Tannock, Ian F., N F Boyd, George Deboer, et al.. (1988). A randomized trial of two dose levels of cyclophosphamide, methotrexate, and fluorouracil chemotherapy for patients with metastatic breast cancer.. Journal of Clinical Oncology. 6(9). 1377–1387. 278 indexed citations

11.

Perrault, D, et al.. (1988). Phase II study of flutamide in patients with metastatic breast cancer. A National Cancer Institute of Canada Clinical Trials Group study. Investigational New Drugs. 6(3). 207–210. 32 indexed citations

12.

Stewart, David J., D Perrault, Jean A. Maroun, & Bernard Lefebvre. (1987). Combined Mitoxantrone Plus Doxorubicin in the Treatment of Breast Cancer. American Journal of Clinical Oncology. 10(4). 335–340. 13 indexed citations

13.

Perrault, D, Joseph M. Herman, Robert J. Burns, et al.. (1985). Echocardiographic abnormalities following cardiac radiation.. Journal of Clinical Oncology. 3(4). 546–551. 50 indexed citations

14.

Perrault, D, et al.. (1984). A randomized comparison of cyclophosphamide-mitoxantrone-5-fluorouracil v cyclophosphamide-doxorubicin-5-fluorouracil in advanced breast cancer: preliminary observations.. PubMed. 11(3 Suppl 1). 23–7. 19 indexed citations

15.

Tannock, Ian F., Charles Erlichman, D Perrault, Ian Quirt, & Malcolm King. (1982). Failure of 5-day vinblastine infusion in the treatment of patients with advanced refractory breast cancer.. PubMed. 66(9). 1783–4. 10 indexed citations

16.

Tc, Brown, T. Chua, D. Dalley, et al.. (1982). Results of treating Hodgkin's disease without a policy of laparotomy staging.. PubMed. 66(4). 717–31. 58 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact